86 related articles for article (PubMed ID: 23570548)
1. Lipid-polymer nanoparticles encapsulating doxorubicin and 2'-deoxy-5-azacytidine enhance the sensitivity of cancer cells to chemical therapeutics.
Su X; Wang Z; Li L; Zheng M; Zheng C; Gong P; Zhao P; Ma Y; Tao Q; Cai L
Mol Pharm; 2013 May; 10(5):1901-9. PubMed ID: 23570548
[TBL] [Abstract][Full Text] [Related]
2. Gelatinases-stimuli nanoparticles encapsulating 5-fluorouridine and 5-aza-2'-deoxycytidine enhance the sensitivity of gastric cancer cells to chemical therapeutics.
Wu FL; Li RT; Yang M; Yue GF; Wang HY; Liu Q; Cui FB; Wu PY; Ding H; Yu LX; Qian XP; Liu BR
Cancer Lett; 2015 Jul; 363(1):7-16. PubMed ID: 25592042
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
4. PEG-detachable lipid-polymer hybrid nanoparticle for delivery of chemotherapy drugs to cancer cells.
Du JB; Song YF; Ye WL; Cheng Y; Cui H; Liu DZ; Liu M; Zhang BL; Zhou SY
Anticancer Drugs; 2014 Aug; 25(7):751-66. PubMed ID: 24590167
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
[TBL] [Abstract][Full Text] [Related]
6. Single-step assembly of DOX/ICG loaded lipid--polymer nanoparticles for highly effective chemo-photothermal combination therapy.
Zheng M; Yue C; Ma Y; Gong P; Zhao P; Zheng C; Sheng Z; Zhang P; Wang Z; Cai L
ACS Nano; 2013 Mar; 7(3):2056-67. PubMed ID: 23413798
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with doxorubicin-loaded galactosylated poly(ethyleneglycol)-lithocholic acid to suppress the tumor growth in an orthotopic mouse model of liver cancer.
Singh B; Jang Y; Maharjan S; Kim HJ; Lee AY; Kim S; Gankhuyag N; Yang MS; Choi YJ; Cho MH; Cho CS
Biomaterials; 2017 Feb; 116():130-144. PubMed ID: 27914985
[TBL] [Abstract][Full Text] [Related]
8. Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells.
Vijayaraghavalu S; Labhasetwar V
Drug Deliv Transl Res; 2018 Oct; 8(5):1289-1299. PubMed ID: 29947019
[TBL] [Abstract][Full Text] [Related]
9. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
11. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
12. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
13. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
14. Smac therapeutic Peptide nanoparticles inducing apoptosis of cancer cells for combination chemotherapy with Doxorubicin.
Li M; Liu P; Gao G; Deng J; Pan Z; Wu X; Xie G; Yue C; Cho CH; Ma Y; Cai L
ACS Appl Mater Interfaces; 2015 Apr; 7(15):8005-12. PubMed ID: 25815797
[TBL] [Abstract][Full Text] [Related]
15. Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy.
Tan S; Sasada T; Bershteyn A; Yang K; Ioji T; Zhang Z
Nanomedicine (Lond); 2014 Apr; 9(5):635-47. PubMed ID: 23905577
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells.
Wang F; Wang YC; Dou S; Xiong MH; Sun TM; Wang J
ACS Nano; 2011 May; 5(5):3679-92. PubMed ID: 21462992
[TBL] [Abstract][Full Text] [Related]
18. Alginate/CaCO3 hybrid nanoparticles for efficient codelivery of antitumor gene and drug.
Zhao D; Liu CJ; Zhuo RX; Cheng SX
Mol Pharm; 2012 Oct; 9(10):2887-93. PubMed ID: 22894610
[TBL] [Abstract][Full Text] [Related]
19. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
Tan ML; Friedhuber AM; Dass CR
J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
[TBL] [Abstract][Full Text] [Related]
20. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
